Reviva Pharmaceuticals Holdings RVPH
OTC RVPH
$0.34 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Reviva Pharmaceuticals Holdings (RVPH) Share-based Compensation (2021 - 2026)

Updated

Reviva Pharmaceuticals Holdings (RVPH) posted Share-based Compensation of $214,565 for Q2 2026, down 45.7% from $395,277 a year earlier and down 63.3% from the prior quarter.

Analysis

Reviva Pharmaceuticals Holdings (RVPH) Share-based Compensation (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Reviva Pharmaceuticals Holdings was $1.71 million, down 22.7% year-over-year; for FY2025, it came in at $2.23 million, up 36.6% from FY2024.

  • Annual Share-based Compensation shows a three-year compound annual growth rate of 132.7% (FY2022 to FY2025).
  • In prior years, Reviva Pharmaceuticals Holdings' Share-based Compensation was $1.63 million in FY2024 (-52.2%), $3.41 million in FY2023 and $176,735 in FY2022.
  • The Q2 2026 figure stands as the lowest quarterly Share-based Compensation since Q1 2023.
  • On a year-over-year basis, Share-based Compensation has declined in each of the last three quarters, with growth averaging 16.5% over the last eight quarters.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was Q3 2023, with growth of 763.4%; the weakest was Q2 2024, with a decline of 86.3%.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $584,439 (Q1 2026), $455,084 (Q4 2025) and $458,379 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 357.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 160.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 234.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 362.00 Mn
10 Reviva Pharmaceuticals Holdings 4.46 Mn -82.75 Mn - 171,021.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 171,021.00
Jun 30, 2026 214,565.00
Mar 31, 2026 600,000.00
Dec 31, 2025 427,859.00
Sep 30, 2025 500,000.00
Jun 30, 2025 395,277.00
Mar 31, 2025 919,119.00
Dec 31, 2024 530,341.00
Sep 30, 2024 348,056.00
Jun 30, 2024 400,000.00
Mar 31, 2024 400,000.00
Dec 31, 2023 390,598.00
Sep 30, 2023 400,000.00
Jun 30, 2023 2.62 Mn
Mar 31, 2023 100,000.00
Dec 31, 2022 79,851.00
Sep 30, 2022 40,587.00
Jun 30, 2022 39,876.00
Mar 31, 2022 39,686.00
Dec 31, 2021 62,034.00
API Access

Reviva Pharmaceuticals Holdings Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RVPH&period=max&api_key=YOUR_API_KEY